Company: SYRA
Filing Date: 2025-02-05
Form Type: S-3/A
Source: 0001493152-25-005032
Chunk: 24

Company: Syra Health Corp
Filing Date: 2025-02-05
Form: S-3/A
Chunk 24
---
 on the amount that may be issued; |

| ● | whether                                                                                                                  
 or not we will issue the series of debt securities in global form, and, if so, the terms and who the depositary will be; |

| ● | the            
 maturity date; |

| ● | whether                                                                                                                          
 and under what circumstances, if any, we will pay additional amounts on any debt securities held by a person who is not a United 
 States person for tax purposes, and whether we can redeem the debt securities if we have to pay such additional amounts;         |

| ● | the                                                                                                                              
 annual interest rate, which may be fixed or variable, or the method for determining the rate and the date interest will begin to 
 accrue, the dates interest will be payable and the regular record dates for interest payment dates or the method for determining 
 such dates;                                                                                                                      |

| ● | whether                                                                                     
 or not the debt securities will be secured or unsecured, and the terms of any secured debt; |

| ● | the                                                            
 terms of the subordination of any series of subordinated debt; |

| ● | the                                
 place where payments will be made; |

| ● | restrictions                                   
 on transfer, sale or other assignment, if any; |

| ● | our                                                                                             
 right, if any, to defer payment of interest and the maximum length of any such deferral period; |

| ● | the                                                                                                                                     
 date, if any, after which, and the price at which, we may, at our option, redeem the series of debt securities pursuant to any optional 
 or provisional redemption provisions and the terms of those redemption provisions;                                                      |

| -15- |

| ● | provisions                                                                                                                       
 for a sinking fund purchase or other analogous fund, if any, including the date, if any, on which, and the price at which we are 
 obligated, pursuant thereto or otherwise, to redeem, or at the holder’s option, to purchase, the series of debt securities       
 and the currency or currency unit in which the debt securities are payable;                                                      |

| ● | whether                                                                                 
 the indenture will restrict our ability or the ability of our subsidiaries, if any, to: |

| ● | incur                    
 additional indebtedness; |

| ● | issue                  
 additional securities; |

| ● | create 
 liens; |

| ● | pay                                                                                                       
 dividends or make distributions in respect of our capital stock or the capital stock of our subsidiaries; |

| ● | redeem         
 capital stock; |

| ●